Compare DPZ & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DPZ | CRL |
|---|---|---|
| Founded | 1960 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 10.8B |
| IPO Year | 2004 | 1999 |
| Metric | DPZ | CRL |
|---|---|---|
| Price | $337.41 | $302.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 12 |
| Target Price | ★ $434.29 | $198.27 |
| AVG Volume (30 Days) | 740.9K | ★ 914.7K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.40% | N/A |
| EPS Growth | ★ 5.27 | N/A |
| EPS | ★ 8.21 | N/A |
| Revenue | ★ $4,939,994,000.00 | $1,857,601,000.00 |
| Revenue This Year | $7.98 | N/A |
| Revenue Next Year | $3.97 | $3.04 |
| P/E Ratio | $41.97 | ★ N/A |
| Revenue Growth | 4.96 | ★ 10.48 |
| 52 Week Low | $282.00 | $144.26 |
| 52 Week High | $469.00 | $300.59 |
| Indicator | DPZ | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 74.13 |
| Support Level | $328.72 | $149.72 |
| Resistance Level | $350.00 | N/A |
| Average True Range (ATR) | 9.69 | 9.31 |
| MACD | -1.82 | 0.03 |
| Stochastic Oscillator | 34.86 | 89.77 |
Domino's is the world's largest pizza chain, surpassing $20 billion in system sales with over 22,100 stores across more than 90 markets at the end of 2025. Around 33% of its units are in the US. The business is 99% franchised. Domino's operates through three segments: supply chain (60% of revenue), US stores (33%), and international franchises (7%). The firm generates the bulk of its revenue by supplying food to stores in the US and Canada through a vertically integrated network of 25 manufacturing and supply chain facilities, which primarily produce and distribute dough, and collecting brand royalties and marketing fees from franchisees. Domino's also generates revenue from sales at company-owned stores.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.